Status:
RECRUITING
PREVENT HPV -Related Cancers Trial
Lead Sponsor:
University of Utah
Collaborating Sponsors:
Kaiser Permanente
University of Arizona
Conditions:
HPV Vaccination
Uptake Vaccination
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will serve as one of the first to develop and test the effectiveness of strategies to promote HPV vaccination among diverse rural parents and caregivers of children ages 9-17 years in the M...
Detailed Description
The clinical trial in the PREVENT study is a patient-randomized control trial (RCT) of two human papillomavirus (HPV) vaccination patient reminder intervention arms that will take place in rural clini...
Eligibility Criteria
Inclusion
- Parents/Caregivers (P/C) of children/adolescents (C/A) ages 9-17 years of age (i.e., age-eligible for HPV vaccination);
- P/C with active clinic patients (i.e., have been seen in the clinic in the last 12 months); and
- P/C who speak either English or Spanish.
Exclusion
- P/C of C/A with previous excluding HPV vaccination history (e.g., completed vaccination, or not due);
- P/C of C/A with clinical conditions that influence the CDC HPV vaccination recommendations (e.g., pregnancy);
- P/C of C/A with other factors that would influence CDC HPV recommendations; and
- P/C that does not speak Spanish or English.
Key Trial Info
Start Date :
October 9 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
519 Patients enrolled
Trial Details
Trial ID
NCT07217145
Start Date
October 9 2025
End Date
February 1 2026
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sea Mar Community Health Centers
Seattle, Washington, United States, 98108